&nbsp;

FEC-D+TRAS-FR.pdf

Dec 1969

Document

FEC-D+TRAS-FR.pdf

Dec 1969

Document

FOLFIRINOX.pdf

Dec 1969

Document

FOLFIRI.pdf

Dec 1969

Guidelines and Advice

First-Line Therapy, Autologous Stem Cell Transplantation, and Post-Transplant Maintenance in the Management of Patients Newly Diagnosed with Mantle Cell Lymphoma

Status: In-Review
ID: RR SCT-9
Version: N/A

Dec 1969

Document

FOLFIRI-FR.pdf

Dec 1969

Document

FOLFIRINOX-FR.pdf

Dec 1969

Regimen

AZCTVENE

Cancer Type:

Hematologic,

Leukemia - Acute Myeloid (AML)

Intent: Palliative

Funding:

New Drug Funding Program

Azacitidine in combination with Venetoclax (Outpatient) - Previously Untreated Acute Myeloid Leukemia

Exceptional Access Program

venetoclax - Venetoclax in combination with azacitidine - Previously untreated acute myeloid leukemia

, Collapse Show fewer tags

Drugs Used:

azaCITIDine,

venetoclax

... Show more tags

Quick Link(s):

Regimen Monograph

Document

ABVD.pdf

Sep 2020

Document

ABVD-FR.pdf

Sep 2020

Regimen

ATEZBEVA

Cancer Type:

Gastrointestinal,

Hepatobiliary / Liver / Bile Duct

Intent: Palliative

Funding:

New Drug Funding Program

Atezolizumab with Bevacizumab (Biosimilar) - Previously Untreated Unresectable or Metastatic Hepatocellular Carcinoma

New Drug Funding Program

Atezolizumab with Bevacizumab (Biosimilar) - Previously Untreated Unresectable or Metastatic Hepatocellular Carcinoma

New Drug Funding Program

Atezolizumab with Bevacizumab (Biosimilar) - Previously Untreated Unresectable or Metastatic Hepatocellular Carcinoma

, Collapse Show fewer tags

Drugs Used:

atezolizumab,

atezolizumab (subcut),

bevacizumab

... Show more tags

Quick Link(s):

Regimen Monograph

Regimen

ACAL

Cancer Type:

Hematologic,

Leukemia - Chronic Lymphocytic (CLL)

Intent: Palliative

Funding:

Exceptional Access Program

acalabrutinib - For the treatment of adult patients with chronic lymphocytic leukemia (CLL), according to clinical criteria